Is The Santa Claus Rally The Gift That Keeps Giving?
Remember the horror of 2008 when the Great Recession hit…
Sell
49
HLNCF Quote, Financials, Valuation and Earnings
Last price:
$4.6200
Seasonality move
:
-3.95%
Day range:
$4.6180 - $4.8000
52-week range:
$3.9000 - $5.3600
Dividend yield:
1.72%
P/E ratio:
27.30x
P/S ratio:
2.98x
P/B ratio:
1.99x
Volume:
8.2K
Avg. volume:
7.7K
1-year change:
14.17%
Market cap:
$41.8B
Revenue:
$14.1B
EPS (TTM):
$0.17
Analysts' Opinion
-
Consensus RatingHaleon PLC has received a consensus rating of --. The company's average rating is a -- based on 0 Buy ratings, 0 Hold ratings, and 0 Sell ratings.
-
Price Target DownsideAccording to analysts' consensus price target of --, Haleon PLC has an estimated downside of -- from its current price of $4.6180.
-
Price Target UpsideAccording to analysts, the highest upside price target is -- representing -100% upside increase from its current price of $4.6180.
Fair Value
-
According to the consensus of 0 analysts, Haleon PLC has -- downside to fair value with a price target of -- per share.
HLNCF vs. S&P 500
-
Over the past 5 trading days, Haleon PLC has underperformed the S&P 500 by -6.55% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Haleon PLC does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Haleon PLC has grown year-over-year revenues for 3 quarters straight. In the most recent quarter Haleon PLC reported revenues of $3.6B.
Earnings Growth
-
Haleon PLC has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Haleon PLC reported earnings per share of $0.07.
Enterprise value:
52.3B
EV / Invested capital:
--
Price / LTM sales:
2.98x
EV / EBIT:
18.47x
EV / Revenue:
3.67x
PEG ratio (5yr expected):
16.28x
EV / Free cash flow:
--
Price / Operating cash flow:
--
Enterprise value / EBITDA:
18.47x
Gross Profit (TTM):
$8.6B
Return On Assets:
3.21%
Net Income Margin (TTM):
10.85%
Return On Equity:
5.94%
Return On Invested Capital:
4.19%
Operating Margin:
25.36%
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-09-30 | 2023-09-30 | 2024-09-30 | 2023-09-30 | 2024-09-30 | |
| Income Statement | ||||||
| Revenue | $12.1B | $15.1B | $14.3B | $3.5B | $3.6B | |
| Gross Profit | $7.6B | $9.1B | $8.6B | $2.2B | $2.3B | |
| Operating Income | $2.1B | $2.8B | $2.7B | $739.5M | $917.4M | |
| EBITDA | $2.1B | $2.9B | $2.8B | $739.5M | $931.7M | |
| Diluted EPS | $0.19 | $0.17 | $0.17 | $0.05 | $0.07 | |
| Period Ending | 2020-09-30 | 2021-09-30 | 2022-09-30 | 2023-09-30 | 2024-09-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | -- | -- | -- | -- | -- | |
| Total Assets | -- | -- | -- | -- | -- | |
| Current Liabilities | -- | -- | -- | -- | -- | |
| Total Liabilities | -- | -- | -- | -- | -- | |
| Total Equity | -- | -- | -- | -- | -- | |
| Total Debt | -- | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2023-06-30 | 2024-06-30 | |
| Cash Flow Statement | ||||||
| Cash Flow Operations | $2.4B | -- | -- | $937.5M | $1.1B | |
| Cash From Investing | -- | -- | -- | -$235.3M | $296.5M | |
| Cash From Financing | -- | -- | -- | -$848.6M | -$2B | |
| Free Cash Flow | -- | -- | -- | $757.3M | $921M | |
HLNCF
Sector
Market Cap
$41.8B
$339.9M
Price % of 52-Week High
86.16%
73.76%
Dividend Yield
1.72%
0%
Shareholder Yield
--
2.64%
1-Year Price Total Return
14.17%
-13.42%
Beta (5-Year)
--
0.504
Dividend yield:
1.72%
Annualized payout:
$0.00
Payout ratio:
31.66%
Growth streak:
0 years
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Technicals
8-day SMA
Sell
Level
$4.7595
200-day SMA
Buy
Level
$4.5040
Bollinger Bands (100)
Sell
Level
4.6368 - 5.0768
Chaikin Money Flow
Buy
Level
894.2K
20-day SMA
Sell
Level
$4.7466
Relative Strength Index (RSI14)
Sell
Level
43.5760
ADX Line
Sell
Level
13.7933
Williams %R
Buy
Level
-98.0952
50-day SMA
Sell
Level
$4.7189
MACD (12, 26)
Buy
Level
0.0105
25-day Aroon Oscillator
Buy
Level
72
On Balance Volume
Neutral
Level
3.4M
Financial Scores
Hold
Altman Z-Score
(Annual)
Level (2.6824)
Buy
CA Score
(Annual)
Level (-0.1674)
Buy
Beneish M-Score
(Annual)
Level (-2.6342)
--
Momentum Score
Level (--)
Buy
Ohlson Score
Level (-1.0123)
Buy
Piotroski F Score
(Annual)
Level (7)
--
Quality Ratio Score
Level (--)
Sell
Fundamental Score
Level (4)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Haleon is one of the largest consumer health companies in the world. Formed by a combination of consumer health divisions of GSK, Pfizer, and Novartis, Haleon separated from GSK and went public in July 2022. The firm generates 60% of sales from global power brands including Sensodyne, Advil, Centrum, and Poligrip, that play in many geographies and are often leaders in their respective categories. It also has a number of local brands, including Emergen-C, Eno, Tums, and Caltrate, that are more tailored to regional needs and have strong local brand equity. Overall, Haleon's brands tackle a variety of silos within consumer health including oral care, digestive health, pain relief, and nutrition.
Stock Forecast FAQ
In the current month, HLNCF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The HLNCF average analyst price target in the past 3 months is --.
-
Where Will Haleon PLC Stock Be In 1 Year?
According to analysts, the consensus estimate is that Haleon PLC share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Haleon PLC?
Analysts are divided on their view about Haleon PLC share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Haleon PLC is a Sell and believe this share price will rise from its current level to --.
-
What Is Haleon PLC's Price Target?
The price target for Haleon PLC over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is HLNCF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Haleon PLC is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of HLNCF?
You can purchase shares of Haleon PLC via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, TastyTrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Haleon PLC shares.
-
What Is The Haleon PLC Share Price Today?
Haleon PLC was last trading at $4.6200 per share. This represents the most recent stock quote for Haleon PLC. Yesterday, Haleon PLC closed at $4.6180 per share.
-
How To Buy Haleon PLC Stock Online?
In order to purchase Haleon PLC stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Alphabet an Undervalued Growth Stock to Buy?
Alphabet (NASDAQ:GOOGL) is easily one of the most successful companies…
Is Tesla Going to Buy Uber?
Tesla has always been in the habit of making large,…
Stock Ideas
Buy
65
Is AAPL Stock a Buy?
Market Cap: $3.9T
P/E Ratio: 42x
Buy
57
Is NVDA Stock a Buy?
Market Cap: $3.4T
P/E Ratio: 118x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $3.3T
P/E Ratio: 37x
Alerts
Buy
87
PSIX alert for Dec 25
Power Solutions International [PSIX] is up 27.42% over the past day.
Buy
65
TSLL alert for Dec 25
Direxion Daily TSLA Bull 2X Shares [TSLL] is up 19.46% over the past day.
Buy
75
SMLR alert for Dec 25
Semler Scientific [SMLR] is up 15.37% over the past day.
